Bisphosphonate Use Does Not Impact Survival in Patients with Pancreatic Cancer: A Propensity Score Matching Analysis

BACKGROUND/AIMS: Bisphosphonates are increasingly recognized for their anti-neoplastic properties, which are the result of their action on the mevalonate pathway. Our primary aim was to investigate the association between bisphosphonate use and survival in patients with pancreatic cancer. Since stat...

Descripción completa

Detalles Bibliográficos
Autores principales: Zylberberg, Haley M., Rustgi, Sheila D., Yang, Anthony, Aronson, Anne, Kessel, Elizabeth, Amin, Sunil, Lucas, Aimee L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of Gut and Liver 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8444100/
https://www.ncbi.nlm.nih.gov/pubmed/34158422
http://dx.doi.org/10.5009/gnl20297

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8444100/
https://www.ncbi.nlm.nih.gov/pubmed/34158422
http://dx.doi.org/10.5009/gnl20297

Ejemplares similares